-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Perspective Therapeutics Inc (CATX)
-
-
-
-
-
-
-
BTIG Starts Perspective Therapeutics Inc (CATX) at Buy, PT $14
-
-
-
-
-
-
-
Perspective Therapeutics data accepted for ESMO Congress presentation
-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Lowered to $15 at RBC Capital
-
-
-
-
-
-
-
Perspective Therapeutics, Inc. (CATX) Reports In-Line Q3 EPS
-
-
-
-
-
-
-
Perspective Therapeutics Inc (CATX) PT Lowered to $27 at RBC Capital
-
-
-
-
-
-
-
Perspective Therapeutics (CATX) Announces 1-for-10 Reverse Stock Split
416,831 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

